| 000 | 01743 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513031907.0 | ||
| 264 | 0 | _c19951011 | |
| 008 | 199510s 0 0 eng d | ||
| 022 | _a1059-1524 | ||
| 024 | 7 |
_a10.1091/mbc.6.5.509 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrady, E F | |
| 245 | 0 | 0 |
_aDelineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor. _h[electronic resource] |
| 260 |
_bMolecular biology of the cell _cMay 1995 |
||
| 300 |
_a509-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line, Transformed |
| 650 | 0 | 4 |
_aCell Membrane _xmetabolism |
| 650 | 0 | 4 |
_aClathrin _xphysiology |
| 650 | 0 | 4 |
_aCoated Vesicles _xmetabolism |
| 650 | 0 | 4 |
_aEndocytosis _xdrug effects |
| 650 | 0 | 4 |
_aEndosomes _xchemistry |
| 650 | 0 | 4 | _aEpitopes |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aOligopeptides |
| 650 | 0 | 4 | _aPeptides |
| 650 | 0 | 4 |
_aPotassium _xphysiology |
| 650 | 0 | 4 |
_aProtein Synthesis Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProton-Translocating ATPases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptor, IGF Type 2 _xanalysis |
| 650 | 0 | 4 |
_aReceptors, Neurokinin-1 _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Transferrin _xanalysis |
| 650 | 0 | 4 |
_aSubstance P _xmetabolism |
| 650 | 0 | 4 |
_aSucrose _xpharmacology |
| 700 | 1 | _aGarland, A M | |
| 700 | 1 | _aGamp, P D | |
| 700 | 1 | _aLovett, M | |
| 700 | 1 | _aPayan, D G | |
| 700 | 1 | _aBunnett, N W | |
| 773 | 0 |
_tMolecular biology of the cell _gvol. 6 _gno. 5 _gp. 509-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1091/mbc.6.5.509 _zAvailable from publisher's website |
| 999 |
_c7544488 _d7544488 |
||